Grignon D - Search Results

1

Cancer as a marker of genetic medical disease: an unusual case of medullary carcinoma of the kidney.

Adsay NV, deRoux SJ, Sakr W, Grignon D. Adsay NV, et al. Among authors: grignon d. Am J Surg Pathol. 1998 Feb;22(2):260-4. doi: 10.1097/00000478-199802000-00017. Am J Surg Pathol. 1998. PMID: 9500230

2

Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Liao JD, Adsay NV, Khannani F, Grignon D, Thakur A, Sarkar FH. Liao JD, et al. Among authors: grignon d. Histol Histopathol. 2007 Jun;22(6):661-76. doi: 10.14670/HH-22.661. Histol Histopathol. 2007. PMID: 17357096 Free PMC article. Review.

3

Urothelial carcinoma with villoglandular differentiation: a study of 14 cases.

Lim M, Adsay NV, Grignon D, Osunkoya AO. Lim M, et al. Among authors: grignon d. Mod Pathol. 2009 Oct;22(10):1280-6. doi: 10.1038/modpathol.2009.97. Epub 2009 Jul 10. Mod Pathol. 2009. PMID: 19593329 Free article.

4

Benign prostatic hyperplasia: it is a premalignant lesion?

Grignon D, Sakr W. Grignon D, et al. In Vivo. 1994 May-Jun;8(3):415-8. In Vivo. 1994. PMID: 7528557 Review.

5

High frequency of mutator phenotype in human prostatic adenocarcinoma.

Gao X, Wu N, Grignon D, Zacharek A, Liu H, Salkowski A, Li G, Sakr W, Sarkar F, Porter AT, et al. Gao X, et al. Among authors: grignon d. Oncogene. 1994 Oct;9(10):2999-3003. Oncogene. 1994. PMID: 8084604

6

Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.

Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Gao X, et al. Among authors: grignon d. Cancer Res. 1993 Jun 15;53(12):2723-7. Cancer Res. 1993. PMID: 8504411

7

A gene from human chromosomal band 3p21.1 encodes a highly conserved arginine-rich protein and is mutated in renal cell carcinomas.

Shridhar V, Rivard S, Shridhar R, Mullins C, Bostick L, Sakr W, Grignon D, Miller OJ, Smith DI. Shridhar V, et al. Among authors: grignon d. Oncogene. 1996 May 2;12(9):1931-9. Oncogene. 1996. PMID: 8649854

8

Mutations in the arginine-rich protein gene, in lung, breast, and prostate cancers, and in squamous cell carcinoma of the head and neck.

Shridhar R, Shridhar V, Rivard S, Siegfried JM, Pietraszkiewicz H, Ensley J, Pauley R, Grignon D, Sakr W, Miller OJ, Smith DI. Shridhar R, et al. Among authors: grignon d. Cancer Res. 1996 Dec 15;56(24):5576-8. Cancer Res. 1996. PMID: 8971156

9

Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.

Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon D, Miller OJ, Sun QC, Petros J, Smith DI. Shridhar V, et al. Among authors: grignon d. Oncogene. 1997 Mar 20;14(11):1269-77. doi: 10.1038/sj.onc.1201100. Oncogene. 1997. PMID: 9178887

10

Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years?

Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP, Pontes JE. Powell IJ, et al. Among authors: grignon d. J Urol. 2000 Jan;163(1):146-8; discussion 148-9. J Urol. 2000. PMID: 10604333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

399 results

Search Page

Filters